Abenovelab
0780.558.109 · rovalta.com · 24/09/2026
Abenovelab
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBOAbenovelab is a Private limited company incorporated in 2022. Its main activity is: Specialist medical practice activities. Its registered office is in Koksijde.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0780.558.109
- Incorporation
- 17/01/2022
- Legal form
- Private limited company
- Registered office
- Hostenstraat(Kok) 14
8670 Koksijde · FlandreSee on map - Contributed capital
- 1 000,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 213,7 k € | -3.0% | 220,3 k € | +1.2% | 217,7 k € | +144% | 89,1 k € |
| EBITDA | 213,6 k € | -2.8% | 219,7 k € | +0.9% | 217,7 k € | +144% | 89,1 k € |
| Operating result | 211,2 k € | -2.0% | 215,5 k € | +0.9% | 213,7 k € | +145% | 87,3 k € |
| Net result | 168,5 k € | -3.1% | 173,8 k € | +5.8% | 164,2 k € | +137% | 69,3 k € |
| Balance sheet | |||||||
| Equity | 43,1 k € | -89.4% | 407,6 k € | +74.3% | 233,9 k € | +236% | 69,7 k € |
| Total assets | 223 k € | -52.0% | 464,7 k € | +59.9% | 290,6 k € | +209% | 94,1 k € |
| Cash | 23,5 k € | -68.7% | 75,2 k € | +36.4% | 55,1 k € | -27.6% | 76,1 k € |
| Debts | 176,9 k € | +225% | 54,4 k € | -0.4% | 54,6 k € | +141% | 22,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 17/01/2022 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 9 months |
| Filing date | 13/04/2026 | 07/04/2025 | 25/03/2024 | 20/03/2023 |
| General meeting | 20/03/2026 | 21/03/2025 | 15/03/2024 | 17/03/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025168,5 k €↓
- 2025Name changeAbenovelab BV
- 2024Annual accounts 2024173,8 k €↑
- 2023Annual accounts 2023164,2 k €↑
- 2022Annual accounts 202269,3 k €
- 17/01/2022IncorporationPrivate limited company
- 2022Name changeVan Den Abeele Tim dr.